146 related articles for article (PubMed ID: 15877204)
1. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series.
Franco LM; Krishnamurthy V; Bali D; Weinstein DA; Arn P; Clary B; Boney A; Sullivan J; Frush DP; Chen YT; Kishnani PS
J Inherit Metab Dis; 2005; 28(2):153-62. PubMed ID: 15877204
[TBL] [Abstract][Full Text] [Related]
2. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports.
Manzia TM; Angelico R; Toti L; Cillis A; Ciano P; Orlando G; Anselmo A; Angelico M; Tisone G
Transplant Proc; 2011 May; 43(4):1181-3. PubMed ID: 21620082
[TBL] [Abstract][Full Text] [Related]
3. [Hepatic adenoma and hepatocellular carcinoma in 3 brothers with type I glycogenosis].
Kharsa G; Degott C; Filoche B; Hedde JP; Potet F; Benhamou JP
Gastroenterol Clin Biol; 1990; 14(1):84-9. PubMed ID: 2155841
[TBL] [Abstract][Full Text] [Related]
4. A case of glycogen storage disease IA with multiple hepatic tumors managed by transcatheter arterial embolization and an acarbose diet.
Endoh A; Inoue N; Katoh T; Nakamura T; Sugimura H; Ohzeki T
J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):333-6. PubMed ID: 11593132
[No Abstract] [Full Text] [Related]
5. Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.
Brooks ED; Landau DJ; Everitt JI; Brown TT; Grady KM; Waskowicz L; Bass CR; D'Angelo J; Asfaw YG; Williams K; Kishnani PS; Koeberl DD
J Inherit Metab Dis; 2018 Nov; 41(6):965-976. PubMed ID: 30043186
[TBL] [Abstract][Full Text] [Related]
6. Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature.
Fink AS; Appelman HD; Thompson NW
Surgery; 1985 Jan; 97(1):117-24. PubMed ID: 3855331
[TBL] [Abstract][Full Text] [Related]
7. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
9. Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia.
Cho JH; Lee YM; Bae SH; Chou JY
Biochem Biophys Res Commun; 2020 Jan; 522(1):1-7. PubMed ID: 31735334
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonographic features of hepatic adenomas in type I glycogen storage disease.
Bowerman RA; Samuels BI; Silver TM
J Ultrasound Med; 1983 Feb; 2(2):51-4. PubMed ID: 6302304
[TBL] [Abstract][Full Text] [Related]
11. Management of hepatic adenoma in glycogen storage disease Ia.
Rosh JR; Collins J; Groisman GM; Schwersenz AH; Schwartz M; Miller CM; LeLeiko NS
J Pediatr Gastroenterol Nutr; 1995 Feb; 20(2):225-8. PubMed ID: 7714690
[No Abstract] [Full Text] [Related]
12. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
13. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).
Rake JP; Visser G; Labrune P; Leonard JV; Ullrich K; Smit GP
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S20-34. PubMed ID: 12373567
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Adenomas and Carcinoma in Asymptomatic, Non-Cirrhotic Type III Glycogen Storage Disease.
Oterdoom LH; Verweij KE; Biermann K; Langeveld M; van Buuren HR
J Gastrointestin Liver Dis; 2015 Dec; 24(4):515-8. PubMed ID: 26697579
[TBL] [Abstract][Full Text] [Related]
15. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
16. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.
Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W
World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875
[TBL] [Abstract][Full Text] [Related]
17. Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type 1a (von Gierke disease).
Gossmann J; Scheuermann EH; Frilling A; Geiger H; Dietrich CF
Transplantation; 2001 Jul; 72(2):343-4. PubMed ID: 11477366
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
Chiu LY; Kishnani PS; Chuang TP; Tang CY; Liu CY; Bali D; Koeberl D; Austin S; Boyette K; Weinstein DA; Murphy E; Yao A; Chen YT; Li LH
J Gastroenterol; 2014 Aug; 49(8):1274-84. PubMed ID: 24129885
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
